Louise Chen

Stock Analyst at Scotiabank

(3.19)
# 1,179
Out of 5,032 analysts
300
Total ratings
45.99%
Success rate
1.67%
Average return

Stocks Rated by Louise Chen

Sarepta Therapeutics
Jun 6, 2025
Upgrades: Sector Outperform
Price Target: $80
Current: $22.51
Upside: +255.40%
Aclaris Therapeutics
May 9, 2025
Maintains: Sector Outperform
Price Target: $15$9
Current: $1.90
Upside: +373.68%
Edgewise Therapeutics
Apr 3, 2025
Downgrades: Sector Perform
Price Target: $50$14
Current: $15.06
Upside: -7.01%
Gain Therapeutics
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $1.87
Upside: +541.71%
Innoviva
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $55
Current: $17.27
Upside: +218.47%
PTC Therapeutics
Mar 7, 2025
Initiates: Sector Perform
Price Target: $55
Current: $65.95
Upside: -16.60%
Perspective Therapeutics
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $15
Current: $4.49
Upside: +234.08%
Palvella Therapeutics
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $50
Current: $73.15
Upside: -31.65%
Ardelyx
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $15
Current: $5.03
Upside: +198.21%
Cogent Biosciences
Mar 7, 2025
Initiates: Sector Outperform
Price Target: $17
Current: $16.39
Upside: +3.72%
Initiates: Sector Outperform
Price Target: $70
Current: $47.89
Upside: +46.17%
Initiates: Sector Outperform
Price Target: $50
Current: $16.38
Upside: +205.25%
Initiates: Sector Outperform
Price Target: $30
Current: $10.05
Upside: +198.51%
Initiates: Sector Outperform
Price Target: $55
Current: $28.27
Upside: +94.59%
Reiterates: Overweight
Price Target: n/a
Current: $2.21
Upside: -
Reiterates: Overweight
Price Target: $160
Current: $54.37
Upside: +194.28%
Reiterates: Overweight
Price Target: n/a
Current: $42.39
Upside: -
Maintains: Overweight
Price Target: $200$240
Current: $229.57
Upside: +4.54%
Reiterates: Overweight
Price Target: $45
Current: $24.51
Upside: +83.60%
Reiterates: Overweight
Price Target: $215
Current: $193.22
Upside: +11.27%
Reiterates: Overweight
Price Target: n/a
Current: $10.81
Upside: -
Reiterates: Overweight
Price Target: $155
Current: $84.79
Upside: +82.80%
Reiterates: Overweight
Price Target: n/a
Current: $17.26
Upside: -
Reiterates: Overweight
Price Target: $885
Current: $802.83
Upside: +10.24%
Reiterates: Overweight
Price Target: n/a
Current: $6.40
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $17.51
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $17.07
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $6.90
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $101.52
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $0.98
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $1.64
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $19.64
Upside: -
Reiterates: Overweight
Price Target: n/a
Current: $0.93
Upside: -
Reiterates: Neutral
Price Target: $925
Current: $578.05
Upside: +60.02%
Reiterates: Overweight
Price Target: n/a
Current: $0.75
Upside: -
Reiterates: Overweight
Price Target: $65
Current: $3.71
Upside: +1,652.02%
Reiterates: Overweight
Price Target: $5
Current: $1.73
Upside: +189.02%
Reiterates: Overweight
Price Target: $25
Current: $5.77
Upside: +333.28%
Reiterates: Overweight
Price Target: $50
Current: $15.08
Upside: +231.56%
Reiterates: Overweight
Price Target: $50
Current: $20.88
Upside: +139.46%
Reiterates: Neutral
Price Target: $5
Current: $1.25
Upside: +300.00%
Maintains: Overweight
Price Target: $5$9
Current: $0.38
Upside: +2,279.69%
Initiates: Overweight
Price Target: $1,687,500
Current: $2.08
Upside: +81,129,707.69%
Maintains: Neutral
Price Target: $240$258
Current: $286.67
Upside: -10.00%
Maintains: Neutral
Price Target: $9$15
Current: $19.31
Upside: -22.32%
Maintains: Overweight
Price Target: $40$50
Current: $1.29
Upside: +3,775.97%
Initiates: Overweight
Price Target: $20
Current: $1.52
Upside: +1,215.79%
Initiates: Overweight
Price Target: $45
Current: $7.17
Upside: +527.62%